Ratnakar Securities Pvt. Ltd.

TATVA CHINTAN PHARMA CHEM LTD.

NSE : TATVABSE : 543321ISIN CODE : INE0GK401011Industry : ChemicalsHouse : Private

BSE1120.0020.8 (+1.89 %)

PREV CLOSE ( ) 1099.20

OPEN PRICE ( ) 1108.80

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 70

TODAY'S LOW / HIGH ( )1108.80 1127.65

52 WK LOW / HIGH ( )1063.35 1888.05

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 12-06 1996

Management Info

Chintan Nitinkumar Shah - Chairman Chintan Nitinkumar Shah - Managing Director

Registered Office

Address Plot No 502/17,G I D C Estate,Ankleshwar,
Bharuch,
Gujarat-393002

Phone 07574848533 / 34

Email chintan@tatvachintan.com

Website www.tatvachintan.com

Registrars Details

Link Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

07May Tatva Chintan Pharma Chem informs abou
Tatva Chintan Pharma Chem has informed that it enclosed Transcript of th..

16Mar Tatva Chintan Pharma Chem submits anal
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..

27Jan Tatva Chintan Pharma Chem informs abou
Pursuant to Securities and Exchange Board of India (Listing Obligations..

17Jan Tatva Chintan Pharma Chem informs abou
Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure..

08Sep Tatva Chintan Pharma Chem informs abou
Tatva Chintan Pharma Chem has informed that the Exchange has received th..

Financials

in Millions

	QTR Mar 24	ANNUAL 24
Net Profit	82.4700000000001	293.48
Gross Profit	122.76	422.65
Operating Profit	187.25	743.73
Net Sales	939.31	3786.77

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Elantas Beck India (BSE) 11595.00 (2.46%)	M.Cap ( in Cr)8971.72
Balaji Amines (BSE) 2297.00 (3.93%)	M.Cap ( in Cr)7160.95
Premier Explosives (BSE) 2453.75 (2.15%)	M.Cap ( in Cr)2582.74
Paushak (BSE) 5221.05 (0.83%)	M.Cap ( in Cr)1595.89
Vinati Organics (BSE) 1660.00 (2.33%)	M.Cap ( in Cr)16816.12

Shareholding Pattern

	PROMOTERS	72.02%
	MUTUAL FUNDS/UTI	12.84%
	NON-INSTITUTION	11.49%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
ICICI Pru MNC Fund(G)	0.79
PGIM India Small Ca...	0.72
Mirae Asset Healthc...	0.70
Nippon India ELSS T...	0.58
ICICI Pru Smallcap ...	0.45
SBI Magnum Midcap F...	0.41

attention investors
kyc
ipo
ibt trading

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

TATVA CHINTAN PHARMA CHEM LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES